Michael P. Brown

机构：Royal Adelaide Hospital, SA Health, Centre for Cancer Biology, Adelaide University, The University of Adelaide, Stanford University · ORCID：0000-0002-5796-1932

发表论文 424 篇 · 总被引 19111 次 · h-index 60

代表论文

• Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers (2024 · Journal for ImmunoTherapy of Cancer · 被引 66)
• Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study (2025 · The Lancet Oncology · 被引 55)
• Antibody drug conjugates: hitting the mark in pancreatic cancer? (2023 · Journal of Experimental & Clinical Cancer Research · 被引 37)
• Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma (2023 · Frontiers in Immunology · 被引 27)
• Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma (2024 · Clinical & Translational Immunology · 被引 16)
• Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy (2023 · Frontiers in Immunology · 被引 12)